Northwestern Medicine scientists have identified a link between Huntington’s disease and dysfunction of the subthalamic nucleus, a component of the basal ganglia, a group of brain structures critical for movement and impulse control.
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.
Northwestern investigators want to know why some people are immune to age-related cognitive decline. Their answers could inform future therapies for neurodegenerative diseases like Alzheimer’s.
Northwestern Medicine scientists have identified one of the molecular mechanisms behind the variability of holoprosencephaly, a congenital brain malformation.
Les Turner ALS Symposium Gathers Scientists, Patients and Experts to Celebrate Research, Patient Care and Education
Physicians, patients, scientists and supporters gathered at the 6th Annual Les Turner Symposium on ALS and NeuroRepair to share research updates, provide patient education and foster new scientific collaborations.
New research from Northwestern Medicine and the Rehabilitation Institute of Chicago scientists has identified the brain region responsible for the placebo response to pain.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
Dimitri Krainc, MD, PhD, Aaron Montgomery Ward Professor and chair of Neurology, has received the Javits Award from the National Institute of Neurological Disorders and Stroke.
Huda Zoghbi, MD, recipient of the inaugural Mechthild Esser Nemmers Prize in Medical Science at Northwestern University, gave a presentation on her research journey studying the neurological disorder Rett syndrome.
The National Institute on Aging has renewed funding for the Cognitive Neurology and Alzheimer’s Disease Center, supporting an additional five years of research, and marking 25 years of continuous grant support.